Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 810.00
+25.60 (3.26%)
Jul 31, 2026, 3:30 PM IST
Anthem Biosciences Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 20,073 | 21,293 | 18,502 | 14,202 | 10,579 | 12,408 |
Revenue Growth | -2.18% | 15.09% | 30.28% | 34.24% | -14.74% | 12.24% |
Gross Profit Gross Profit Growth | 12,377 | 12,750 | 10,687 | 7,948 | 7,005 | 8,137 |
Operating Income Operating Income Growth | 6,640 | 7,085 | 5,882 | 4,246 | 3,725 | 5,197 |
Net Income Net Income Growth | 5,759 | 5,918 | 4,513 | 3,673 | 3,852 | 4,055 |
Earnings Per Share EPS Growth | 10.11 | 10.43 | 8.04 | 6.48 | 6.75 | 7.11 |
EPS Growth | 12.46% | 29.73% | 24.11% | -4.03% | -5.04% | 43.27% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Contract Research Development & Manufacturing Services (CRDMO) Contract Research Development & Manufacturing Services (CRDMO) Growth | 16,608 | 17,727 | 15,061 | 8,976 | 8,081 | 9,472 |
Speciality Ingredients Speciality Ingredients Growth | 3,415 | 3,516 | 3,385 | 3,362 | 2,488 | 2,840 |
Total Total Growth | 20,023 | 21,243 | 18,446 | 14,194 | 10,569 | 12,313 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 9,385 | 9,385 | 4,837 | 6,429 | 8,351 | 6,109 |
Total Debt Total Debt Growth | 539.24 | 539.24 | 1,133 | 2,385 | 1,262 | 577.84 |
Net Cash (Debt) Net Cash Growth | 8,846 | 8,846 | 3,704 | 4,044 | 7,090 | 5,531 |
Net Cash Growth | 42.91% | 138.80% | -8.41% | -42.96% | 28.17% | 286.71% |
Net Cash Per Share Net Cash Per Share Growth | 15.53 | 15.59 | 6.60 | 7.13 | 12.43 | 9.70 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 8,445 | 2,706 | 1,402 | 3,060 | 3,329 |
Capital Expenditures CapEx Growth | - | -2,112 | -2,612 | -2,900 | -1,889 | -1,558 |
Free Cash Flow Free Cash Flow Growth | - | 6,333 | 93.43 | -1,499 | 1,171 | 1,771 |
Free Cash Flow Growth | - | 6678.51% | - | - | -33.91% | 9.44% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 61.66% | 59.88% | 57.76% | 55.96% | 66.21% | 65.58% |
Operating Margin | 33.08% | 33.27% | 31.79% | 29.89% | 35.21% | 41.89% |
Pretax Margin | 38.99% | 38.71% | 35.50% | 33.61% | 47.01% | 44.02% |
Profit Margin | 28.69% | 27.79% | 24.39% | 25.86% | 36.41% | 32.68% |
FCF Margin | - | 29.74% | 0.51% | -10.55% | 11.06% | 14.27% |
| Fiscal Year | Current | FY 2026 |
|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.25% | 0.31% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 80.06 | 62.28 | - | - | - | - |
Forward PE | 60.22 | 54.93 | - | - | - | - |
P/FCF Ratio | 71.96 | 58.20 | - | - | - | - |
PS Ratio | 22.70 | 17.31 | - | - | - | - |